Free Preparation Discussions
MENU
ACDIS CCDS-O Exam - Topic 5 Question 5 Discussion
Topic #: 5
review]
Clinic documentation states: ''Follow-up for post-induction chemotherapy for metastatic uterine cancer.'' To BEST identify the conditions being monitored and treated, a CDI specialist should
When documentation states ''metastatic uterine cancer,'' the most important missing element for complete, accurate outpatient coding is where the cancer has metastasized (the secondary site[s]). In ambulatory CDI, identifying secondary sites best clarifies the full scope of disease being monitored and treated because metastatic disease coding relies on documenting both the primary malignancy and the specific metastatic location(s) (e.g., lung, liver, bone, peritoneum, lymph nodes). This supports correct severity representation, risk capture, treatment intent, and medical necessity for ongoing chemotherapy follow-up. While tumor morphology can be clinically relevant, it is usually established earlier in the diagnostic pathway and does not, by itself, define current metastatic burden. Likewise, reviewing labs or MRI results may provide supportive indicators, but they do not replace provider documentation of the confirmed metastatic sites being managed. A compliant query focused on secondary sites prompts the provider to document the current metastatic disease status (active, responding, progressing) and specific locations, which most directly identifies the conditions under treatment.
Mertie
12 hours agoBuddy
6 days agoMelda
11 days agoSue
16 days agoLorrie
21 days agoJennie
26 days agoKaitlyn
1 month agoRobt
1 month agoEdelmira
1 month agoStefany
2 months agoKaran
2 months agoLeonor
2 months agoJoseph
2 months agoElvera
2 months agoNovella
4 months agoHarley
4 months agoOllie
4 months agoCrista
4 months agoIlona
4 months agoSue
5 months agoTegan
5 months agoCaren
5 months agoColette
5 months agoIrving
5 months agoBettyann
5 months agoCurt
6 months ago